U.S. Markets closed

Akers Biosciences, Inc. (AKER)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.98+0.47 (+8.53%)
At close: 4:00PM EDT

5.96 -0.02 (-0.33%)
After hours: 7:52PM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.61
52-Week Change 3-44.41%
S&P500 52-Week Change 3N/A
52 Week High 316.32
52 Week Low 31.55
50-Day Moving Average 34.26
200-Day Moving Average 33.48

Share Statistics

Avg Vol (3 month) 31.21M
Avg Vol (10 day) 31.03M
Shares Outstanding 56.13M
Float 4.42M
% Held by Insiders 10.83%
% Held by Institutions 19.30%
Shares Short (Jul 14, 2020) 4109.16k
Short Ratio (Jul 14, 2020) 40.14
Short % of Float (Jul 14, 2020) 41.78%
Short % of Shares Outstanding (Jul 14, 2020) 41.78%
Shares Short (prior month Jun 14, 2020) 4103.67k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:24
Last Split Date 3Nov 24, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-468.58%

Management Effectiveness

Return on Assets (ttm)-48.14%
Return on Equity (ttm)-110.49%

Income Statement

Revenue (ttm)1.33M
Revenue Per Share (ttm)1.28
Quarterly Revenue Growth (yoy)-40.60%
Gross Profit (ttm)478.75k
EBITDA -6.15M
Net Income Avi to Common (ttm)-6.51M
Diluted EPS (ttm)-6.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.44M
Total Cash Per Share (mrq)1.57
Total Debt (mrq)270.46k
Total Debt/Equity (mrq)3.97
Current Ratio (mrq)3.81
Book Value Per Share (mrq)2.19

Cash Flow Statement

Operating Cash Flow (ttm)-4.29M
Levered Free Cash Flow (ttm)-3.11M